Works by Yoneda, Kazue


Results: 31
    1

    Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer.

    Published in:
    NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00350-7
    By:
    • Katayama, Yuki;
    • Yamada, Tadaaki;
    • Tanimura, Keiko;
    • Tokuda, Shinsaku;
    • Morimoto, Kenji;
    • Hirai, Soichi;
    • Matsui, Yohei;
    • Nakamura, Ryota;
    • Ishida, Masaki;
    • Kawachi, Hayato;
    • Yoneda, Kazue;
    • Hosoya, Kazutaka;
    • Tsuji, Takahiro;
    • Ozasa, Hiroaki;
    • Yoshimura, Akihiro;
    • Iwasaku, Masahiro;
    • Kim, Young Hak;
    • Horinaka, Mano;
    • Sakai, Toshiyuki;
    • Utsumi, Takahiro
    Publication type:
    Article
    2

    HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00250-8
    By:
    • Tanimura, Keiko;
    • Yamada, Tadaaki;
    • Okada, Koutaroh;
    • Nakai, Kunihiro;
    • Horinaka, Mano;
    • Katayama, Yuki;
    • Morimoto, Kenji;
    • Ogura, Yuri;
    • Takeda, Takayuki;
    • Shiotsu, Shinsuke;
    • Ichikawa, Kosuke;
    • Watanabe, Satoshi;
    • Morimoto, Yoshie;
    • Iwasaku, Masahiro;
    • Kaneko, Yoshiko;
    • Uchino, Junji;
    • Taniguchi, Hirokazu;
    • Yoneda, Kazue;
    • Matoba, Satoaki;
    • Sakai, Toshiyuki
    Publication type:
    Article
    3

    HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00250-8
    By:
    • Tanimura, Keiko;
    • Yamada, Tadaaki;
    • Okada, Koutaroh;
    • Nakai, Kunihiro;
    • Horinaka, Mano;
    • Katayama, Yuki;
    • Morimoto, Kenji;
    • Ogura, Yuri;
    • Takeda, Takayuki;
    • Shiotsu, Shinsuke;
    • Ichikawa, Kosuke;
    • Watanabe, Satoshi;
    • Morimoto, Yoshie;
    • Iwasaku, Masahiro;
    • Kaneko, Yoshiko;
    • Uchino, Junji;
    • Taniguchi, Hirokazu;
    • Yoneda, Kazue;
    • Matoba, Satoaki;
    • Sakai, Toshiyuki
    Publication type:
    Article
    4
    5

    Salvage surgery combined with descending aorta resection for lung cancer.

    Published in:
    Surgical Case Reports, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1186/s40792-019-0675-9
    By:
    • Kanayama, Masatoshi;
    • Ichiki, Yoshinobu;
    • Mori, Masataka;
    • Matsumiya, Hiroki;
    • Nabe, Yusuke;
    • Taira, Akihiro;
    • Shinohara, Shinji;
    • Kuwata, Taiji;
    • Takenaka, Masaru;
    • Hirai, Ayako;
    • Imanishi, Naoko;
    • Yoneda, Kazue;
    • Ikushima, Eigo;
    • Yasutsune, Toru;
    • Nishimura, Yosuke;
    • Tanaka, Fumihiro
    Publication type:
    Article
    6

    Fenestration without rib resection for postoperative bronchopleural fistula.

    Published in:
    Surgical Case Reports, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1186/s40792-019-0629-2
    By:
    • Kanayama, Masatoshi;
    • Ichiki, Yoshinobu;
    • Yoshimatsu, Katsuma;
    • Takeda, Yusuke;
    • Kusanagi, Kasumi;
    • Ishida, Teruaki;
    • Mori, Masataka;
    • Matsumiya, Hiroki;
    • Nabe, Yusuke;
    • Taira, Akihiro;
    • Shinohara, Shinji;
    • Kuwata, Taiji;
    • Takenaka, Masaru;
    • Hirai, Ayako;
    • Imanishi, Naoko;
    • Yoneda, Kazue;
    • Tanaka, Fumihiro
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Podoplanin: An emerging cancer biomarker and therapeutic target.

    Published in:
    Cancer Science, 2018, v. 109, n. 5, p. 1292, doi. 10.1111/cas.13580
    By:
    • Krishnan, Harini;
    • Rayes, Julie;
    • Miyashita, Tomoyuki;
    • Ishii, Genichiro;
    • Retzbach, Edward P.;
    • Sheehan, Stephanie A.;
    • Takemoto, Ai;
    • Chang, Yao‐Wen;
    • Yoneda, Kazue;
    • Asai, Jun;
    • Jensen, Lasse;
    • Chalise, Lushun;
    • Natsume, Atsushi;
    • Goldberg, Gary S.
    Publication type:
    Article
    22
    23
    24

    Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM).

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, p. 472, doi. 10.1245/s10434-013-3399-2
    By:
    • Yoneda, Kazue;
    • Tanaka, Fumihiro;
    • Kondo, Nobuyuki;
    • Hashimoto, Masaki;
    • Takuwa, Teruhisa;
    • Matsumoto, Seiji;
    • Okumura, Yoshitomo;
    • Tsubota, Noriaki;
    • Sato, Ayuko;
    • Tsujimura, Tohru;
    • Kuribayashi, Kozo;
    • Fukuoka, Kazuya;
    • Tabata, Chiharu;
    • Nakano, Takashi;
    • Hasegawa, Seiki
    Publication type:
    Article
    25

    Circulating Endothelial Cell (CEC) as a Diagnostic and Prognostic Marker in Malignant Pleural Mesothelioma (MPM).

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2012, v. 19, n. 13, p. 4229, doi. 10.1245/s10434-012-2506-0
    By:
    • Yoneda, Kazue;
    • Tanaka, Fumihiro;
    • Kondo, Nobuyuki;
    • Orui, Hayato;
    • Hashimoto, Masaki;
    • Takuwa, Teruhisa;
    • Matsumoto, Seiji;
    • Okumura, Yoshitomo;
    • Tsubota, Noriaki;
    • Sato, Ayuko;
    • Tsujimura, Tohru;
    • Kuribayashi, Kozo;
    • Fukuoka, Kazuya;
    • Nakano, Takashi;
    • Hasegawa, Seiki
    Publication type:
    Article
    26
    27
    28
    29
    30

    A liquid biopsy in primary lung cancer.

    Published in:
    Surgery Today, 2019, v. 49, n. 1, p. 1, doi. 10.1007/s00595-018-1659-2
    By:
    • Yoneda, Kazue;
    • Imanishi, Naoko;
    • Ichiki, Yoshinobu;
    • Tanaka, Fumihiro
    Publication type:
    Article
    31